Related references
Note: Only part of the references are listed.Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients
Young Jin Choi et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression
Koji Morimoto et al.
CANCER SCIENCE (2009)
Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
Tomonori Tanei et al.
CLINICAL CANCER RESEARCH (2009)
Poor hormone receptor expression in East African breast cancer: Evidence of a biologically different disease?
P. A. Bird et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Expression of EGFR and c-kit is associated with the basal-like phenotype in breast carcinomas of African women
Hawa Nalwoga et al.
APMIS (2008)
Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma
I. B. Engelsen et al.
BRITISH JOURNAL OF CANCER (2008)
Cancer of the breast: 5-year survival in a tertiary hospital in Uganda
A. Gakwaya et al.
BRITISH JOURNAL OF CANCER (2008)
Molecular subtypes of breast cancers detected in mammography screening and outside of screening
Hard Sihto et al.
CLINICAL CANCER RESEARCH (2008)
Lesson of the Month - Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1
J. B. Arnes et al.
HISTOPATHOLOGY (2008)
Basal-like breast cancer: A critical review
Emad A. Rakha et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Loss of BMI-1 expression is associated with clinical progress of malignant melanoma
Ingeborg M. Bachmann et al.
MODERN PATHOLOGY (2008)
HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
H. Korkaya et al.
ONCOGENE (2008)
The CD44(+)/CD24(-) phenotype is enriched in basal-like breast tumors
Gabriella Honeth et al.
BREAST CANCER RESEARCH (2008)
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
Christine M. Fillmore et al.
BREAST CANCER RESEARCH (2008)
Frequency of the basal-like phenotype in African breast cancer
Hawa Nalwoga et al.
APMIS (2007)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Bmi-1 cooperates with H-ras to transform human mammary epithelial cells via Dysregulation of multiple growth-regulatory pathways
Sonal Datta et al.
CANCER RESEARCH (2007)
Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients - A single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results Database
Gloria J. Morris et al.
CANCER (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
Marc Tischkowitz et al.
BMC CANCER (2007)
Differences in risk factors for breast cancer molecular subtypes in a population-based study
Xiaohong R. Yang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients
Javier Silva et al.
BREAST CANCER RESEARCH (2007)
Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas
Ingeborg B. Engelsen et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Basal-like breast carcinomas: clinical outcome and response to chemotherapy
S. Banerjee et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells
Suling Liu et al.
CANCER RESEARCH (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients
IM Stefansson et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer
GV Glinsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Cancer survival in Kampala, Uganda
A Gondos et al.
BRITISH JOURNAL OF CANCER (2005)
Breast cancer in sub-Saharan Africa: How does it relate to breast cancer in African-American women?
A Fregene et al.
CANCER (2005)
African American white differences in breast carcinoma - p53 alterations and other tumor characteristics
BA Jones et al.
CANCER (2004)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
BRCA1 functions as a breast stem cell regulator
WD Foulkes
JOURNAL OF MEDICAL GENETICS (2004)
Racial differences in the expression of cell cycle regulatory proteins in breast carcinoma - Study of young African American and white women in Atlanta, Georgia
PL Porter et al.
CANCER (2004)
Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer
JH Kim et al.
BREAST (2004)
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer
WD Foulkes et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer:: a retrospective study -: Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens
NE Sládek et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Validation of tissue microarray technology in breast carcinoma
RL Camp et al.
LABORATORY INVESTIGATION (2000)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
